Collectively, these findings suggest that obesity-induced inflammation interfering with the cAMP-dominated signal transduction pathway through secondary IR and related inflammatory factors, stimulating CYP19 transcription and elevating the aromatase level. This evidence concerns the gene CYP19A1 and obesity disorder.